Atlas Trials

First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00308750 · COMPLETED

Trial details

NCT number
NCT00308750
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2006-03-01
Primary completion
2009-07-01
Enrollment
218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.